Gangwen Han

3.7k citations
39 papers · 2.9k indexed · 1 hit paper · h-index 25

Gangwen Han

39 papers receiving 2.8k citations

Hit Papers

Caspase 3–mediated stimulation of tumor cell repopulation...7062011202620162021200400600

Peers

Gangwen Han
Comparison fields: 5 of 110
  • Rehabilitation 277
  • Cancer Research 506
  • Dermatology 276
  • Immunology 645
  • Oncology 697
Replace Tracy Tabib with:
Tracy Tabib United States
R. Dover United Kingdom
Wendy C. Weinberg United States
Molly Kulesz‐Martin United States
Jesús M. Paramio Spain
Adam Giangreco United Kingdom
Delphine Javelaud France
K T Yeo United States
Mario A. Anzano United States
Howard Edington United States
Gangwen Han relative to Tracy Tabib United States Tracy Tabib's profile →
Citations per field
00.5×10×14.4×
Tracy Tabib · 1×
Citations per year

Countries citing papers authored by Gangwen Han

Since Specialization
Citations

This map shows the geographic impact of Gangwen Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gangwen Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gangwen Han more than expected).

Fields of papers citing papers by Gangwen Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gangwen Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gangwen Han. The network helps show where Gangwen Han may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gangwen Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gangwen Han Line = papers co-authored together Gangwen Han links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20214
3 202025
4 202021
5 201810
6 201815
7 201541
8 20156
9 201328
10 20138
11 2012111
12 201133
13
A Role for TGFb Signaling in the Pathogenesis of Psoriasis
20102
14 201044
15 201033
16 200942
17 200855
18 2006129
19 200517
20 2004179

About Gangwen Han

Gangwen Han is a scholar working on Urology, Rehabilitation and Developmental Biology, having authored 39 papers that have together received 2.9k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (15 papers), Kruppel-like factors research (9 papers), Wound Healing and Treatments (7 papers), Psoriasis: Treatment and Pathogenesis (6 papers), Cancer-related gene regulation (6 papers), Hair Growth and Disorders (5 papers), Hedgehog Signaling Pathway Studies (5 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Rehabilitation (277 citations), Cancer Research (506 citations) and Dermatology (276 citations). Gangwen Han has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Xiao‐Jing Wang, Philip Owens, David Raben, Fulun Li, Aik Choon Tan, Shi‐Long Lu, Allen G. Li, Wenrong Li, Fei‐Fei Liu and Fang Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026